Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial - Sharma, M; Molina, CA; Toyoda, K (Lancet Neurol, 2024)